SHANGHAI (Reuters) -Innovent Biologics' newly launched weight-loss drug is making inroads in its home market of China, ...

Swiss drugmaker Roche signalled its ambition to join Eli Lilly and Novo Nordisk at the top of the booming weight-loss market ...

Novo Nordisk , the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to ...

On September 10, Novo Nordisk shared in a press release that it intends to eliminate 9,000 positions from its global ...

Novo Nordisk said participants who took the once-daily pill in a clinical trial lost an average 16% of their body weight.

Makers of GLP-1 drugs, including Novo Nordisk, Eli Lilly and others, are close to releasing daily pills to help shed pounds ...

Patients on daily pill lost about 17% of body weight in trial Results nearly identical to injectable Wegovy New obesity pill ...

The FDA's warnings to Eli Lilly, Novo Nordisk and Hims & Hers spotlight risks for ETFs tied to the weight-loss drug boom.

Novo Nordisk announced an 11% workforce reduction, cutting 9,000 jobs amid rising competition in obesity treatments. The ...

The video, "An Oprah Special: Shame, Blame, and the Weight Loss Revolution," mentioned Lilly's Zepbound and Mounjaro, as well ...

Phase 3 trial results showed the once-weekly Cagrilintide monotherapy injection helped patients reduce their weight by 11.8% ...

Healthcare company Novo Nordisk ($NVO) has reported promising results from its latest clinical trial for its obesity treatment. Notably, tripling ...